6719 abstracts found.



Results filter

Tolerability and efficacy of Rolapitant for prevention of Chemotherapy induced nausea and vomiting: A systematic review and meta-analysis of active-controlled trials.

Year:

Session type:

Theme:

Hussien Ahmed1,Ali Mohamed Hammad2,Mohamed Zidan3,Mohamed Salem4,Ahmed Negida5
1Faculty of Medicine Zagazig University,2Faculty of Medicine, Cairo University, Cairo, Egypt.,35Faculty of Medicine, Tanta University, Egypt.,4Faculty of Medicine, Al Azhar University, Cairo, Egypt,5School of Medicine, Liverpool University, UK

Enterosorption as a supportive treatment during external radiotherapy in patients with uterine and cervical cancer

Year:

Session type:

Theme:

Visnja Matkovic1,Kristina Katic2,Ante Corusic2,Robert Likic3
1University clinic for Obstetrics and Gynecology, KBC Zagreb,Department of Gynecologic Oncology,2Department of gynaecologic oncology, Clinic for Obstetrics and Gynecology, University Hospital Centre Zagreb,3Department of Clinical Pharmacology, University Hospital Centre Zagreb, Zagreb

Outcome of patients with solid malignancies and suspected Pneumocystis jiroveci pneumonia (PJP)

Year:

Session type:

Theme:

Juliet Carmichael1,Melissa Balcorta1,Unell Riley1,Timothy Wigmore1,Alicia Okines1,Nadia Yousaf1
1The Royal Marsden Hospital

HAEMOGLOBIN CONCENTRATION IN FAECES FROM ONE TO 48 HOURS AFTER SAMPLING USING THREE FIT ANALYTICAL SYSTEMS

Year:

Session type:

Theme:

Cerin John1,Carolyn Piggott1,Helen Bruce1
1NHS Bowel Cancer Screening Programme -Southern Hub

Change in tobacco and alcohol consumption following a diagnosis of head and neck cancer: results from Head and Neck 5000

Year:

Session type:

Theme:

Chris Penfold1,Andrea Waylen1,Steve Thomas2,Andy Ness1
1Bristol Nutrition BRU,2University Hospitals Bristol NHS Foundation Trust

Smoking and alcohol consumption as predictors of outcome in head and neck cancer: results from the Head and Neck 5000 study.

Year:

Session type:

Theme:

Rhona Beynon1,Steve Thomas2,Andrea Waylen1,Chris Penfold1,Richard Martin1,Andy Ness1
1The University of Bristol,2The University of Bristol, Bristol Royal Infirmary

A preliminary study to compare cfDNA levels in lung cancer cases and high risk controls to evaluate the role of cfDNA levels in early lung cancer detection

Year:

Session type:

Theme:

Fiona Taylor1,Shobha Silva2,Barbara Ottolini3,James Bradford2,Penella Woll2,Dawn Teare2,Jacqui Shaw3,Cox Angela2
1Weston Park Hospital,2University of Sheffield,3University of Leicester

Pre-natal medical radiation exposure in pediatric blood cancers: single institution study, 1990-2015

Year:

Session type:

Theme:

Robin Rohrer1
1Seton Hill University

FIT sample stability for haemoglobin-positive faeces using three analytical systems over seven days

Year:

Session type:

Theme:

Carolyn Piggott1,Cerin John1,Helen Bruce1
1NHS Bowel Cancer Screening Programme Southern Hub

A comparison of the yield from endoscopic surveillance in detecting early gastric cancer in CDH1+ve versus CDH1-ve HDGC families

Year:

Session type:

Theme:

Emma Mi1,Ella Mi1,Marc Tischkowitz2,Susan Richardson3,Massimiliano di Pietro4,Krish Ragunath5,Maria O’Donovan6,Rebecca Fitzgerald7
1University of Cambridge School of Clinical Medicine,2Department of Medical Genetics, University of Cambridge and Cambridge University Hospitals NHS Trust,3Familial Gastric Cancer Registry, Department of Oncology, Cambridge University Hospitals NHS Trust,4MRC Cancer Unit, Hutchison-MRC Research Centre, Cambridge,5Nottingham Digestive Diseases Centre, Nottingham University Hospitals NHS Trust,6Department of Histopathology, Cambridge University Hospitals NHS Trust,7MRC Cancer Cell Unit, University of Cambridge

Socioeconomic Deprivation and the Burden of Head and Neck Cancer- Regional variations of Incidence and Mortality in Merseyside and Cheshire, North West, England.

Year:

Session type:

Theme:

Bilal G Taib1,Jill Oakley2,Yvonne Daley3,Ian Hodge4,Paul Wright2,Ruth du Plessis5,Joseph Rylands6,David Taylor-Robinson7,Sue Povall7,Andrew Schache6,Richard Shaw6,Ann Dingle4,Terry Jones7
1Royal Liverpool University Hospital,2Cheshire West and Chester Public Health Team,3Public Health England,4Cheshire and Merseyside Strategic Clinical Networks,5Cheshire and Merseyside Collaborative Service,6Aintree University Hospital,7University of Liverpool

Using text mining to automatically extract radiation esophagitis from free-text clinical narratives for clinical decision support

Year:

Session type:

Theme:

Azad Dehghan1,Tom Liptrot1,Kardo Ala’aldeen1,Daniel Tibble1,Matthew Barker-Hewitt1,Linda Ashcroft1,Fiona Blackhall1,Corinne Faivre-Finn1
1The Christie NHS Foundation Trust

Clinical features and Histological subtypes of RCC. Single center experience

Year:

Session type:

Theme:

Faisal Azam1,Waleed Mohammed Al Selwi2,Samir Taha Fotih2,Osama Zeid Abduljalil2,Ahmed Mohammed Wbari2,Fahad Ibnshamsah2,Faisal Azam2
1King Fahad Specialist Hospital,2King Fahad Specialist Hospital, Dammam

Incidence and progression of Barrett’s oesophagus in clinical practice: A cohort analysis for planning of the Barrett’s ESophagus Trial 3 (BEST3) comparing the Cytosponge-TFF3 test with usual care

Year:

Session type:

Theme:

Judith Offman1,Francesca Pesola1,Rebecca Fitzgerald2,Willie Hamilton3,Peter Sasieni1
1Queen Mary, University of London,2MRC Cancer Cell Unit, University of Cambridge,3University of Exeter

Metabolism biomarkers measured before prostate cancer diagnosis and second primary tumours: a prospective study in the Swedish AMORIS cohort.

Year:

Session type:

Theme:

Cecilia Bosco1,Hans Garmo1,Niklas Hammar2,Göran Walldius2,Ingmar Jungner2,Håkan Malmström2,Lars Holmberg2
1King's college london,2Karolinska Institutet

Survival prognosis following diagnosis of metastatic renal cell carcinoma: is performance status alone a sufficient predictor?

Year:

Session type:

Theme:

Anna Street1,Hannah Copley1,Olivia Fraser1,Wojciech Cymes2,Athena Matakidou1,Tim Eisen1,Kate Fife1
1Addenbrooke's Hospital,2Addenbroooke's Hospital

The GASTROS Study: Standardising Outcome Reporting in Gastric Cancer Surgery Research

Year:

Session type:

Theme:

Bilal Alkhaffaf1,Iain Bruce1,Anne-Marie Glenny2,Paula Williamson3,Jane Blazeby4
1Central Manchester University Hospitals NHS Foundation Trust,2University of Manchester,3University of Liverpool,4University of Bristol

Concomitant use of antiacids in patients with advanced hepatocellular carcinoma (HCC) receiving sorafenib therapy

Year:

Session type:

Theme:

Razwan Razak1,Victoria Kunene2,Yuk Ting Ma2
1University of Birmingham,2NHS Trust

The Management of Ductal Carcinoma In-Situ at Charing Cross Hospital

Year:

Session type:

Theme:

Helen Saxby1,Hamoun Rozati1,Sami Shousa1,Susan Cleator1
1Charing Cross Hospital

Characterisation of the Arachidonic Acid Metabolising Pathway in Colorectal Cancer

Year:

Session type:

Theme:

Graeme Murray1,Abdo Alnalbulsi1,Rebecca Swan1,Beatriz Cash2,Ayahm Alnabulsi2
1University of Aberdeen,2Vertebrate Antibodies

OUTCOME OF OPEN DISTAL PANCREATECTOMY: AN AUDIT AT TERTIARY CARE HOSPITAL

Year:

Session type:

Theme:

Amyna Jiwani1,Tabish Chawla1
1Aga Khan University Hospital

The Effectiveness and Challenges of Data Oriented Patient Assessment: A Case Study in Head and Neck Cancer

Year:

Session type:

Theme:

Jonny Edwards1,James Moor1,Vin Paleri2,Sheila Fellows2
1LifeQueue,2Newcastle University Teaching Hospitals NHS Trust

Neoadjuvant Chemoradiotherapy in Resectable Oesophageal Cancer Patients: UK Practice

Year:

Session type:

Theme:

Caitlin Bowden1,Sarah Gwynne2,Paul Shaw3
1Velindre Cancer centre,2South West Wales Cancer Centre,3Velindre Cancer Centre

Adjuvant radiotherapy after therapeutic lymph node dissection in high-risk Stage III melanoma: the Cambridge experience

Year:

Session type:

Theme:

Lakshmi Harihar1,Amer Durrani2,Sarah Jefferies2,Richard Benson2,Kate Fife2
1Addenbrooke's Hospital,2Addenbrooke's Hospital, Cambridge

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

Year:

Session type:

Theme:

Muhammad Alvi1,Maurice Loughrey2,Philip Dunne3,Stephen McQuaid1,Richard Turkington3,Marc-Aurel Fuchs1,Claire McGready1,Victoria Bingham1,Brendan Pang4,Perry Maxwell1,Jacqueline James1,Graeme Murray5,Richard Wilson3,Manuel Salto-Tellez1
1Northern Ireland Molecular Pathology Laboratory,2Belfast Health and Social Care Trust,3Queen's University Belfast,4National University Health System, Singapore,5University of Aberdeen

Post chemotherapy hydration and acute kidney injury in patients undergoing concurrent cisplatin chemoradiotherapy (CRT) for head and neck cancers

Year:

Session type:

Theme:

Jacqueline Grove1,Joanna Mackenzie1,Aravindhan Sundaramurthy1
1Western General Hospital

A comprehensive analysis of immunotherapy trials reveals a paucity of translational research endpoints in trial design

Year:

Session type:

Theme:

Sophie Raby1,Dr Claire Connell2,Dr Tobias Janowitz2
1The Christie,2Addenbrookes Hospital

The HeartSpare Plus 1A Trial: A dosimetric comparison of breast radiotherapy techniques to treat locoregional lymph nodes including the internal mammary chain (IMC)

Year:

Session type:

Theme:

Alison Ranger1,Alex Dunlop2,Katie Hutchinson3,Marjory Mclennan3,Hannah Chantler3,Nikki Twyman3,Christopher Rose4,Helen Convery1,Ellen Donovan1,Emma Harris5,Charlotte Coles3,Anna Kirby1
1The Royal Marsden NHS Foundation Trust,2The Royal Marsden NHS Trust,3Cambridge University Hospitals Trust,4Cambridge Hospitals University Trust,5The Institute of Cancer Research

Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer: Applicability and Clinical Relevance

Year:

Session type:

Theme:

Sanjit Agrawal1,Rosina Ahmed1,Sachin Shenoy1
1Tata Medical Center

The correlation between quantitative parameters in mutiparametric MRI and PI-RADS 2.0.

Year:

Session type:

Theme:

Bowen Jin1,Cheng Wei1,Magdalena Szewczyk-Bieda1,Ghulam Nabi1
1University of Dundee

Medicinal Plants from Oman Inhibit Growth of Ovarian and Breast Cancer Cells

Year:

Session type:

Theme:

Sadri Said1,Md Sohail Akhtar1,Afaf Weli1,Qasim Alriyami1,Sulaiman Alkhanjari1,Tamimi Yahya2
1University of Nizwa,2Sultan Qaboos University

TARDOX: Early Results of a Phase I Study of Targeted Delivery of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) By Focused-Ultrasound Hyperthermia for Liver Tumours

Year:

Session type:

Theme:

Paul Lyon1,Lang'O Odondi1,Lucy Boyle1,Christophoros Mannaris2,Michael Gray2,Daniel Chung3,Aarti Shah3,Robert Carlisle4,Feng Wu5,Mark Middleton4,Fergus Gleeson3,Constantin Coussios2
1University of Oxford,2Institute of Biomedical Engineering, University of Oxford, Oxford, UK,3Department of Radiology, Oxford University Hospitals, Oxford, UK,4Department of Oncology, University of Oxford, Oxford, UK,5Nuffield Department of Surgery, John Radcliffe Hospital, Headington, Oxford

FOCUS4-D: Results of a randomised, placebo controlled trial of AZD8931 (HER1, 2, 3 inhibitor) in advanced/metastatic colorectal cancer tumours that are wildtype for BRAF, PIK3CA, KRAS & NRAS

Year:

Session type:

Theme:

Richard Adams1,Ewan Brown2,Louise Brown3,Rachel Butler4,Stephen Falk5,David Fisher3,Richard Kaplan3,Phillip Quirke6,Susan Richman6,Leslie Samuel7,Jenny Seligman6,Matthew Seymour6,Kaikeen Shiu8,Harpreet Wasan9,Richard Wilson10,Timothy Maughan11,On behalf of The FOCUS4 Trial Investigators12
1Cardiff University and Velindre Cancer Centre,2Edinburgh Cancer Centre,3MRC Clinical Trials Unit at UCL,4All Wales Genetics Laboratory, University of Wales,5UH Bristol NHS Foundation Trust,6University of Leeds,7Aberdeen Royal Infirmary,8University College London Hospitals Trust,9Imperial College London,10Queen's University Belfast,11University of Oxford,12Collaboration

Discovery of G protein-coupled receptor 158 as a potential glioma biomarker

Year:

Session type:

Theme:

Ying Zhang1,Ningning Li1,Kastytis Sidlauskas1,Shu An1,Matthew Ellis1,Angela Richart-Londt1,Jessica Broni1,Joanne Lau1,Sebastian Brandner1
1University College London

Preliminary activity in the first in human study of the first-in-class fatty acid synthase (fasn) inhibitor, tvb-2640

Year:

Session type:

Theme:

Sreeja Aruketty1,Gerald Falchook2,Manish Patel3,Andrew Brenner4,Jeffrey Infante5,Erkut Borazanci6,Juanita Lopez7,Kathleen Moore8,Peter Schmid9,Arthur Frankel10,Emma Dean11,John Sarantopoulos4,Suzanne Jones5,Mariane Sousa Fontes12,Louise Lim9,Todd M Bauer5,Judy Wang3,William McCulloch13,George Kemble13,Marie O'Farrell13,Katharine Grimmer13,Howard Burris5,Hendrik-Tobias Arkenau14
1Experimental Cancer Medicine Team, The Christie NHS Trust,2Sarah Cannon Research Institute at HealthONE, Denver, CO, USA,3Sarah Cannon Research Institute/Florida Cancer Specialists, FL, USA,4Cancer Therapy & Research Center, San Antonio, TX, USA,5Sarah Cannon Research Institute/Tennessee Oncology, TN, USA,6HonorHealth Research Institute/Translational Genomics Research Institute, AZ, USA,7The Royal Marsden/Institute of Cancer Research, Sutton, UK,8Sarah Cannon Research Institute University of Oklahoma, OK, USA,9Barts Cancer Institute, London, UK,10University of Texas Southwestern Medical Center, Dallas, TX, USA,11Experimental Cancer Medicine Team, The Christie NHS Trust, Manchester, UK,12The Royal Marsden NHS Foundation Trust, Sutton, UK,133-V Biosciences, Menlo Park, CA, USA,14Sarah Cannon Research Institute, London, UK

Is there a role for prophylactic G-CSF in breast cancer patients receiving docetaxel chemotherapy in combination with carboplatin or cyclophosphamide?

Year:

Session type:

Theme:

Alison Stillie1,Ellie Dickson2,Frances Yuille1
1NHS Lothian,2College of Medicine, University of Edinburgh

INTEREST OF RADIOCHEMOTHERAPY IN THE RECTAL CANCER

Year:

Session type:

Theme:

Messaoud Ayad1,Naima Haoui2
1EHS Centre anti cancer,2Centre anti cancer

BREAST CANCER IN WOMAN YOUNGER THAN 35 YEARS

Year:

Session type:

Theme:

Messaoud Ayad1,Naouel Aksil2
1EHS Centre anti cancer,2Cnetre anti cancer

ADJUVANT CHEMORADIOTHERAPY IN GASTRIC CANCER

Year:

Session type:

Theme:

Messaoud Ayad1,Naouel Aksil2,Naima Haoui2
1EHS Centre anti cancer,2Centre anti cancer

Accuracy of FDG-PET-CT response assessment following (chemo)radiotherapy for locally advanced larynx and hypopharyngeal carcinoma

Year:

Session type:

Theme:

Finbar Slevin1,Sriram Vaidyanathan1,Mehmet Sen1,Andrew F Scarsbrook1,Robin J D Prestwich1
1St James' Institute of Oncology

Between and within patient imaging heterogeneity highlights differences between Vemurafenib, Dabrafenib and Trametinib in metastatic melanoma

Year:

Session type:

Theme:

Hitesh Mistry1,David Orrell2
1University of Manchester,2Systems Forecasting

FAKTION; Phase 1b/2 randomised placebo controlled trial of fulvestrant +/- AZD5363 in postmenopausal women with advanced breast cancer previously treated with a 3rd generation aromatase inhibibitor

Year:

Session type:

Theme:

Robert Jones1,Sacha Howell2,Paul Rugman3,Angela Casbard4,Emily Bongard4
1Velindre,2Manchester University,3Astra-Zeneca,4Cardiff University

TARDOX: Safety and Feasibility of Targeted Delivery of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) By Focused-Ultrasound Hyperthermia for Liver Tumours

Year:

Session type:

Theme:

Lang'O Odondi1,Paul Lyon1,Lucy Boyle1,Feng Wu1,Mark Middleton1,Fergus Gleeson1,Constantin Coussios1
1University of Oxford

Identification and characterisation of cyclic peptide inhibitors of Ras/PI3K and Ras/Raf protein complexes

Year:

Session type:

Theme:

Mohamed (Soly) Ismail1,Mohamed Ismail1,Julian Downward1
1The Francis Crick Institute

What factors influence the patient and primary care intervals in the diagnostic pathway of gynaecological cancers?

Year:

Session type:

Theme:

Pauline Williams1,Peter Murchie1,Christine Bond1,Chris Burton1
1University of Aberdeen

Mammaglobin-A tissue expression and 5-year survival in breast cancer

Year:

Session type:

Theme:

Liz Baker1,Louise Hall2,Deborah Wilson3,Jim France3,Naomi Whiteoal3,Pud Bhaskar3
1North Tees and Hartlepool NHS Foundation Trust,2Royal Victoria Infirmary,3University Hospital of North Tees

THE COLORECTAL CANCER: EPIDEMIOLOGICAL, CLINICAL, THERAPEUTIC AND MOLECULAR PROFIL

Year:

Session type:

Theme:

Messaoud Ayad1,Naouel Aksil2,Naima Haoui2
1EHS Centre anti cancer,2Centre anti cancer

OPTIMA: a prospective randomised trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions

Year:

Session type:

Theme:

Robert Stein1,Andreas Makris2,Luke Hughes-Davies3,Iain Macpherson4,Andrea Marshall5,Amy Campbell5,Peter Hall6,David Cameron6,Helena Earl7,Adele Francis8,Sarah Pinder9,Christopher Poole10,Daniel Rea11,John Bartlett12,Adrienne Morgan13,Leila Rooshenas14,Carmel Conefrey14,Jenny Donovan14,Claire Hulme15,Christopher McCabe16,Victoria Harmer17,Helen Higgins5,Janet Dunn5,On behalf of the OPTIMA Trial Management Group18
1National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK,2Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK,3Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK,4University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK,5Warwick Clinical Trials Unit, University of Warwick, Coventry, UK,6University of Edinburgh, Edinburgh, UK,7University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK,8University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK,9Kings College London, Guy’s Hospital, London, UK,10University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK,11Cancer Research UK Institute for Cancer Studies, Birmingham, UK,12Ontario Institute for Cancer Research, Toronto, Canada,13Independent Cancer Patients' Voice, London, UK,14University of Bristol, Bristol, UK,15Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK,16Department of Emergency Medicine Research, University of Alberta, Edmonton, Canada,17Imperial College Healthcare Trust, London, UK,18Various

LUNG CANCER IN YOUNG PATIENTS: CLINICO-EPIDEMIOLOGICAL AND THERAPEUTIC PROFILE

Year:

Session type:

Theme:

Messaoud Ayad1,Lakhdar Abbas2,Abdelhalim Boudoukha2
1EHS Centre anti cancer,2Centre anti cancer

Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial

Year:

Session type:

Theme:

Pippa Corrie1,Tim Meyer2,Wendi Qian3,Juan Valle4,Denis Talbot5,David Cunningham6,Nicholas Reed7,Lucy Wall8,Justin Waters9,Paul Ross10,Alan Anthoney11,Kate Sumpter12,Naveed Sarwar13,Tom Crosby14,Nazma Begum3,Gemma Young3,Richard Hardy3
1Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0QQ,2Royal Free Hospital, London NHS Foundation Trust, Pond Street, London, NW3 2QG,3Cambridge Cancer Trials Centre | Cambridge Clinical Trials Unit – Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital, Hills Road, Cambridge, CB2 0QQ,4Department of Medical Oncology, University of Manchester, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX,5Department of Oncology, Oxford University Hospitals Trust, Churchill Hospital, Oxford, OX3 7LE,6Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT,7Beatson Oncology Centre, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN,8Edinburgh Cancer Centre, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU,9Kent Oncology Centre, Maidstone Hospital, Hermitage Lane, Maidstone, ME16 9QQ,10Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT,11St James's Institute of Oncology, St James’s University Hospital, Beckett Street, Leeds, LS9 7TF,12Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, NE7 7DN,13Southend University Hospitals NHS Foundation Trust, Prittlewell Chase, Westcliff-on-Sea, Essex, SS0 0RY,14Velindre Cancer Centre, Velindre NHS Trust, Velindre Place, Cardiff, CF14 2TL